Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting

Abstract excerpt

OBJECTIVE: This study seeks to replicate previous results indicating that T102C in the serotonin 2A receptor (HTR2A) and Ser9Gly in the dopamine D3 receptor (DRD3) were associated with a risperidone response to acutely exacerbated schizophrenia, and to determine whether possession of these alleles predicts clinical improvement in a naturalistic setting. METHODS: We consecutively recruited 100 schizophrenia...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neurotransmitter Receptor Influence on Behavior
• Share to Receptor Mechanisms and Signaling